Last year was one of the best yet for marijuana stocks , but 2019 is shaping up to be the biggest year ever for cannabis.
While the industry still conjures up thoughts of recreational smokers getting high, this year the focus will shift to healing and wellness, thanks to the growing uses for CBD. marijuana stocks CBD is short for cannabidiol, one of many compounds found in the marijuana plant. Unlike its more well-known cousin THC, CBD does not get you high. Instead, it promotes wellness, pain relief, and easing of the symptoms of disease.
It’s basically nature’s pharmacy wrapped up in one compound.
And CBD shows enormous promise for treating a variety of symptoms, including post-traumatic stress disorder, autism, schizophrenia, and more. It is also rapidly gaining popularity as a general health treatment, with people taking it for everything from keeping energy up to arthritis. It even helps treat your cats and dogs.
That’s why 2019 will be the "year of CBD," and it could mean another huge year for cannabis stocks … Another Big Step Along the Legalization Road
The passage of the Farm Bill in December effectively "normalized" CBD across the country by making industrial hemp – another form of the marijuana plant and a major source for CBD – legal at the federal level.
Hemp farmers can now access banking services, crop insurance, and even federal grants for research that were previously unavailable. For manufacturers and distributors, it is now crystal clear that it is 100% legal to transport hemp and hemp products – including CBD – across state lines.
[Trending] Four of the Hottest IPOs Set to Hit in 2019 – Find Out How to Profit as Demand for New Cannabis Stocks Heats Up – Click Here …
Moreover, retailers can now sell CBD without fear of enforcement action by the government. Hemp and CBD will be worth about $2 billion this year and as much as $22 billion by 2022, according to cannabis research firm Brightfield Group.
Money Morning Director of Cannabis Investing Research Greg Miller went as far as predicting that 2019 will be remembered as "the year of CBD."
And for good reason.
In March, the United Nations is set to de-schedule CBD, whether sourced from marijuana or hemp, giving CBD products the green light around the globe.
In 2018, the website Marijuana Moment tracked 915 bills in state legislatures and Congress concerning cannabis, medical marijuana, and hemp. A significant percentage of filed marijuana legislation moved forward, with at least 147 bills being signed or enacted in 35 states and the District of Columbia. This year, legislators in state capitols and on Capitol Hill have already filed more than 350 cannabis-related proposals.
All of these catalysts will combine to create a market unlike anything we’ve ever seen before.
Legalization will unleash the pent-up demand of the public and open the floodgates of supply from companies that have been planning and waiting for this to happen.
Within a few months, CBD will be available in a much larger variety of products. You will be able to choose among tinctures (currently the primary form of consumption), gummies, energy shots, nutrition bars, skin moisturizers, and CBD-infused products like honey, coffee, and beer.
And with the rapidly increasing acceptance of cannabis in general and CBD in particular – these products – old and new – will be available in everyday stores across the nation. Ask your friends if they use CBD products already as a supplement or calming skin lotion. The number of positive answers will likely surprise you.
With that sort of pent-up demand brewing just below the surface, jumping into the cannabis market right now – before it goes completely mainstream – could be the profit opportunity of a lifetime.
Here’s exactly how to do it… The Marijuana Stocks We Are Watching Right Now
Click here to view original web page at How Marijuana Stocks Are Getting a Boost from “the Year of CBD”